Diabetes drugs act as powerful curb for immune cells in controlling disease-causing inflammation
In a study published online in Genes and Development Mitchell Lazar and his team found that reducing macrophage activity, the immune system's inflammatory response to tissue damage, can inhibit obesity and diabetes, diseases associated with prolonged inflammation.
FULL STORY AT Penn Medicine News →